New Study Shows YIV-906 Reduces Side Effects in Rectal Cancer Treatment

[vc_row][vc_column][vc_single_image image="62245" img_size="large" css=""][vc_column_text css=""][/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""]The National Foundation for Cancer Research (NFCR) proudly shares new findings from Yale Cancer, highlighting the potential of YIV-906, an experimental botanical drug developed by Dr. Yung-Chi Cheng, a longtime NFCR-supported scientist. A study published in the Journal of Gastrointestinal...